Case Studies

Opportunity AssessmentEvaluation of the market potential for an asset being developed for a chronic respiratory indication

Asset / Portfolio StrategyAssessment of potential lifecycle indications for a small molecule targeted therapy in biomarker-defined solid tumors

Asset SearchAsset search for business development opportunities for a company seeking to expand its rare disease portfolio, focused on central nervous system diseases

BD Analytics Commercial diligence for the selling company in the context of an M&A transaction

Commercial Planning: Competitive Strategy Simulation workshop to prepare for competitive strategy and messaging for a new AML drug

Commercial Planning: Market Readiness Strategy Go-to-market strategy for a novel oncology agent for a rare biomarker selected indication

China Market Entry Strategy Curation of partnering candidates and detailed revenue forecast to support licensing initiatives